ADC Directory, A Guide to the World of Antibody-drug Conjugates

20/03/2024

Listen to the latest episodes of The Onco'Zine Brief

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcar...

20/11/2023

Find the best Biopharmaceuticals Job Listings now. The most recent Job Listings posted by Antibody-drug Conjugates near you.

20/11/2023

Job openings posted in the ADC Directory (a companion to ADC Review | Journal of Antibody-drug Conjugates)

Find the best Biopharmaceuticals Job Listings now. The most recent Job Listings posted by Antibody-drug Conjugates near you.

17/10/2023

REGISTER for our Upcoming Webinar:
Validating Protein Concentration Determination in ADCs with SoloVPE
This live webinar on October 26, 2023 includes a 30-40 minute talk
with 15 minute Q&A
8 AM PDT/ 11 AM EDT/ 3 PM GMT

Click to Register:
- https://conta.cc/3FlcYCI

14/10/2023

Webinar: Validating Protein Concentration of Antibody-Drug Conjugates
This live webinar on October 26, 2023 includes a 30-40 minute talk
with 15 minute Q&A
8 AM PDT/ 11 AM EDT/ 3 PM GMT

Click to Register: https://lnkd.in/d5Qrptz5

11/10/2023

This October, make sure to join the ADC Community at

The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.

27/09/2023

Home Must Read Articles Unlocking the Potential of Antibody-drug ConjugatesMust Read ArticlesOpinionUnlocking the Potential of Antibody-drug ConjugatesBy Toshimitsu Uenaka, Ph.D. - September 27, 2023 FacebookTwitterPinterestWhatsAppReddItLinkedinEmailPrint One hundred years ago, Paul Ehrlich*, a Ger...

14/09/2023

https://conta.cc/3r6XYVB

Validating Protein Concentration Determination in ADCs: Unveiling the SoloVPE Advantage Dear Peter, Validating Protein Concentration Determination in ADCs: Unveiling the SoloVPE Advantage ADCs com

13/09/2023

Remember to register online by this Friday, September 15, 2023 to make the most of our final savings. As a member of ADC Review's network, you can register with code "ADCREVIEW10" to get 10% off your registration. Additional team discounts of up to 20% are also available.
https://conta.cc/485gXQO

Registration Closing Soon!     Hi Peter, Is there a hotter space within oncology R&D right now than within the ADC field? With a surplus of positive clinical readouts, record-breaking high capital col

11/09/2023

Find ADC related news in the ADC Directory at www.adcdirectory.com - The ADC Directory is a membership driven companion to ADC Review / Journal of Antibody-drug Conjugates. Click on the link below to sign up an join the community!

The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.

31/08/2023

Find ADC related news in the ADC Directory at www.adcdirectory.com - companion to ADC Review / Journal of Antibody-drug Conjugates

The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.

22/08/2023

Join the ADC Directory, A Guide to the World of Antibody-drug Conjugates at http://www.adcdirectory.com

17/08/2023

Join Stand Up To Cancer as we celebrate 15 years of groundbreaking cancer research on August 19, 2023 at 8 ET / 7 Central.
https://standuptocancer.org/su2c-show-2023/

03/08/2023

14th World ADC | October 16-19, 2023 | San Diego, CA.
https://conta.cc/3XHz9er

The 14th World ADC Returns to San Diego, CA. As the World's Largest Industry Dedicated Discussion an Network Forum Greetings! The ADC wave shows no sign of breaking with the ground-breaking approval o

31/07/2023

Home Must Read Articles AJICAP Second-generation: Realizing Versatility and Robustness through Fc-Affinity Guided Chemical Conjugation TechnologyMust Read ArticlesPeer ReviewedAJICAP Second-generation: Realizing Versatility and Robustness through Fc-Affinity Guided Chemical Conjugation TechnologyByT...

06/07/2023

The Inaugural ADC Linker & Conjugation Summit is coming to Boston, MA, August 22 – 24, 2023.
Follow the link for more information: https://conta.cc/44dEvk7

The Inaugural ADC Linker & Conjugation Summit is coming to Boston, MA Greetings! Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC fi

03/07/2023

The inaugural ADC Toxicity Summit is coming to Boston, MA | July 25 – 27, 2023 | https://conta.cc/46xGFN6

The inaugural ADC Toxicity Summit is coming to Boston, MA Greetings! A wide therapeutic index is the goal for all ADC developers, and whilst efficacy is undeniable, toxicity remains the single biggest

04/04/2023

https://conta.cc/412KWo6

“Think of ADCs as guided missiles, in which the antibody is the cancer detector andthe cytotoxin the missile’s warhead.”

27/03/2023

Join the The Onco'Zine Brief - Affordable National Sponsorship & Advertising Opportunities Designed to Connect with 75 million Highly Engaged Listeners

https://conta.cc/40Bq1Z5

Connect with 75 million Engaged Listeners     Connect with Engaged Listeners AFFORDABLE NATIONAL SPONSORSHIP & ADVERTISING OPPORTUNITY to 75 million people Hello Peter,   The Onco’Zine Brief® is avail

17/03/2023

Listen to The Onco'Zine Brief - in Episode 101 Peter Hofland talks with Dr. Matthias Bucerius.

Podcast versions: https://lnkd.in/gx5rP97K
PRX | Public Radio Exchange https://lnkd.in/gg_wJQT2-
UK health Radio: https://ukhealthradio.com/blog...

27/02/2023

The Onco'Zine Brief
- Listen on Spreaker - https://bit.ly/TOB-Jan_16_2023
- Listen on UK Health Radio (UKHR) - https://bit.ly/TOBat100onUKHR
- Listen on PRX | Public Radio Exchange - https://bit.ly/TOBat100onPRX

Join as a sponsor/advertiser: https://bit.ly/3Js9H7S

07/02/2023

https://conta.cc/3XcAZlY

Your World ADC London, UK | Full Agenda! Greetings! With over 211 antibody-drug conjugate (ADC) clinical trials breaking ground so far throughout 2022, a plethora of positive clinical results, expansi

30/01/2023

Sunvalley Communication's Conference Coverage offers a broad brand exposure across multiple channels including exclusive placement in our conference/meeting specific news sections, newsletters, along with podcasts and video interviews and specialty online channels during the select conference.

Conference Coverage Sponsorships are available on Onco'Zine (www.oncozine.com) and ADC Review | Journal of Antibody-drug Conjugates (www.adcreview.com) , Beyond Cancer, The Onco'Zine Brief (broadcast/podcast) and the 'Changing Strategies' video series.

Our Conference Coverage is recommended for national and international medical society meetings, congresses and conferences lasting 3 to 5 days.

For more information, contact the sales team: https://www.oncozine.com/advertisement-sponsorship-options/

30/12/2022

Click on the link to read the Onco'Zine and ADC Review newsletter with updates from the San Antonio Breast Cancer Symposium (SABCS): https://conta.cc/3hj7b8p

07/12/2022

https://conta.cc/3P33fES

Imagine a world where cancer therapies kill only the cancer. Dear Peter, Imagine a world where cancer therapies kill only the cancer. Cancer is an enemy that is difficult to defeat. For more t

14/11/2022

https://conta.cc/3hBjk8d

In early November, Actinium Pharmaceuticals reached a primary endpoint with positive results from their Phase 1 clinical trial (NCT03441048) evaluating lintuzumab-Ac225 (Actimab-A), a novel CD33 directed antibody-radiotherapy conjugate (ARC), with salvage chemotherapy regimen CLAG-M in fit patients with relapsed or refractory (R/R) Acute Myeloid Leukemia (AML). These results further cemented the evidence that radiopharmaceuticals will soon be playing a key role in cancers beyond the prostate.

Discover how to use radiopharmaceuticals in conjunction with ADCs at the 4th Annual Targeted Radiopharmaceuticals Europe, the world-leading industry forum designed to overcome the most critical industry challenges facing the field today.

Click to Register for the 4th Annual Targeted Radiopharmaceuticals Summit Europe
https://adc.expert/4th_annual_targeted_radiopharmaceuticals_Europe

TRP | Targeted Radiopharmaceuticals Summit (Europe) Greetings! Extracting the most value from targeting systems in antibody-drug conjugates (ADCs) could require a mind open to the parallel field of ra

09/09/2022

https://conta.cc/3eFnMBt

Download this peer reviewed article from ADC Review | Journal of Antibody-drug Conjugates Greetings! Learn more about validating protein concentrations of Antibody-Drug Conjugates by downloading the p

07/09/2022

https://conta.cc/3KKxcHZ

2nd ADC Target Selection Summit Greetings! We're excited to share with you the official program for the 2nd ADC Target Selection Summit which will be taking place in-person for the first time this yea